{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T05:33:55Z","timestamp":1736400835391,"version":"3.32.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.diabres.2023.110833","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T02:46:54Z","timestamp":1689821214000},"page":"110833","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Optimal medical therapy improves outcomes in patients with diabetes mellitus and acute myocardial infarction"],"prefix":"10.1016","volume":"203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3373-5906","authenticated-orcid":false,"given":"Dongfeng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5426-6937","authenticated-orcid":false,"given":"Hai","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiantao","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Raposeiras-Roub\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emad","family":"Abu-Assi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Paulo Simao Henriques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"D'Ascenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Saucedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Ram\u00f3n Gonz\u00e1lez-Juanatey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen B.","family":"Wilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wouter J.","family":"Kikkert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iv\u00e1n","family":"Nu\u00f1ez-Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Ariza-Sole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Alexopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Liebetrau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuma","family":"Kawaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zenon","family":"Huczek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoping","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiharu","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Correia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masa-aki","family":"Kawashiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Southern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5484-6234","authenticated-orcid":false,"given":"Oliver","family":"Kalpak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2023.110833_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2023.110833_b0010","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1093\/eurjpc\/zwab011","article-title":"Prevalence of diabetes and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities","volume":"28","author":"Mak","year":"2022","journal-title":"EUR J PREV CARDIOL"},{"key":"10.1016\/j.diabres.2023.110833_b0015","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","author":"Sarwar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2023.110833_b0020","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.amjcard.2009.10.048","article-title":"Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry)","volume":"105","author":"Krempf","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.diabres.2023.110833_b0025","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jacc.2003.09.038","article-title":"Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb\/IIIa inhibition: lessons from the GUSTO V trial","volume":"43","author":"Gurm","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diabres.2023.110833_b0030","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1053\/euhj.2000.2244","article-title":"Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen. The TRACE Study Group","volume":"21","author":"Gustafsson","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1016\/j.diabres.2023.110833_b0035","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.diabres.2023.110833_b0040","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","article-title":"ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"33","author":"Steg","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.diabres.2023.110833_b0045","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/hrt.2009.188607","article-title":"The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction","volume":"96","author":"Bramlage","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.diabres.2023.110833_b0050","doi-asserted-by":"crossref","first-page":"744","DOI":"10.2459\/JCM.0000000000000362","article-title":"BleeMACS: rationale and design of the study","volume":"17","author":"D'Ascenzo","year":"2016","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.diabres.2023.110833_b0055","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.644189","article-title":"Type 2 diabetes and myocardial infarction: recent clinical evidence and perspective","volume":"8","author":"Cui","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.diabres.2023.110833_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.110077","article-title":"LPS differentially affects expression of CD14 and CCR2 in monocyte subsets of Post-STEMI patients with hyperglycemia","volume":"191","author":"Blanks","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2023.110833_b0065","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1093\/eurheartj\/ehab128","article-title":"Antithrombotic therapy in diabetes: which, when, and for how long?","volume":"42","author":"Ajjan","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.diabres.2023.110833_b0070","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1161\/CIRCULATIONAHA.106.179294","article-title":"Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association","volume":"115","author":"Buse","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2023.110833_b0075","doi-asserted-by":"crossref","first-page":"6683937","DOI":"10.1155\/2021\/6683937","article-title":"In-hospital peak glycemia in predicting no-reflow phenomenon in diabetic patients with STEMI treated with primary percutaneous coronary intervention","volume":"2021","author":"Liu","year":"2021","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.diabres.2023.110833_b0080","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/ccd.29913","article-title":"Diabetes mellitus is independently associated with early stent thrombosis in patients undergoing drug eluting stent implantation: Analysis from the Victorian cardiac outcomes registry","volume":"99","author":"Nogic","year":"2022","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.diabres.2023.110833_b0085","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.2337\/dc21-0939","article-title":"Hyperglycemia drives stent restenosis in STEMI patients","volume":"44","author":"Mone","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2023.110833_b0090","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9082555","article-title":"The effect of diabetes on prognosis following myocardial infarction treated with primary angioplasty and potent antiplatelet therapy","volume":"9","author":"Simek","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.diabres.2023.110833_b0095","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.jacc.2016.01.069","article-title":"Relationship between infarct size and outcomes following primary PCI: patient-level analysis from 10 randomized trials","volume":"67","author":"Stone","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diabres.2023.110833_b0100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.diabres.2010.01.001","article-title":"Hyperglycemia on admission predicts larger infarct size in patients undergoing percutaneous coronary intervention for acute ST-segment elevation myocardial infarction","volume":"88","author":"Cruz-Gonzalez","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2023.110833_b0105","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/dom.12827","article-title":"Long-term mortality after acute myocardial infarction among individuals with and without diabetes: A systematic review and meta-analysis of studies in the post-reperfusion era","volume":"19","author":"Gholap","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2023.110833_b0110","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.diabres.2023.110833_b0115","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/CIRCULATIONAHA.108.791061","volume":"118","author":"Wiviott","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2023.110833_b0120","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1093\/eurheartj\/ehq325","article-title":"Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial","volume":"31","author":"James","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.diabres.2023.110833_b0125","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12933-015-0232-1","article-title":"Diabetes mellitus and platelet reactivity in patients under prasugrel or ticagrelor treatment: an observational study","volume":"14","author":"Alexopoulos","year":"2015","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabres.2023.110833_b0130","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1016\/j.jcin.2020.07.032","article-title":"Ticagrelor or prasugrel in patients with acute coronary syndromes and diabetes mellitus","volume":"13","author":"Ndrepepa","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.diabres.2023.110833_b0135","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1016\/j.jacc.2020.03.008","article-title":"Ticagrelor with or without aspirin in high-risk patients with diabetes mellitus undergoing percutaneous coronary intervention","volume":"75","author":"Angiolillo","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diabres.2023.110833_b0140","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12933-020-01173-7","article-title":"Impact of diabetes mellitus on the early-phase arterial healing after drug-eluting stent implantation","volume":"19","author":"Ishihara","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabres.2023.110833_b0145","doi-asserted-by":"crossref","unstructured":"10. Cardiovascular disease and risk management: standards of medical care in diabetes-2020. DIABETES CARE 2020; 43:S111-S134.","DOI":"10.2337\/dc20-S010"},{"key":"10.1016\/j.diabres.2023.110833_b0150","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.3346\/jkms.2017.32.10.1603","article-title":"Incidence, predictors, and clinical outcomes of new-onset diabetes mellitus after percutaneous coronary intervention with drug-eluting stent","volume":"32","author":"Chun","year":"2017","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.diabres.2023.110833_b0155","doi-asserted-by":"crossref","first-page":"450","DOI":"10.2337\/dc22-0783","article-title":"Stress hyperglycemia drives the risk of hospitalization for chest pain in patients with ischemia and nonobstructive coronary arteries (INOCA)","volume":"46","author":"Mone","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2023.110833_b0160","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1161\/CIRCULATIONAHA.107.188629","article-title":"Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism","volume":"117","author":"Deedwania","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2023.110833_b0165","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2337\/dc19-2165","article-title":"Screening for glucose perturbations and risk factor management in dysglycemic patients with coronary artery disease-a persistent challenge in need of substantial improvement: a report from ESC EORP EUROASPIRE V","volume":"43","author":"Ferrannini","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2023.110833_b0170","doi-asserted-by":"crossref","unstructured":"Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW. Achievement of goals in U.S. diabetes care, 1999-2010. N Engl J Med 2013; 368:1613-1624.","DOI":"10.1056\/NEJMsa1213829"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882272300596X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882272300596X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T03:44:41Z","timestamp":1736394281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016882272300596X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":34,"alternative-id":["S016882272300596X"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2023.110833","relation":{},"ISSN":["0168-8227"],"issn-type":[{"type":"print","value":"0168-8227"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimal medical therapy improves outcomes in patients with diabetes mellitus and acute myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2023.110833","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110833"}}